RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

Medicine & Life Sciences

• Aminoglycosides 8%
• Anti-Bacterial Agents 5%
• Antisense Oligonucleotides 9%
• Bacterial Infections 7%
• Clinical Trials 5%
• Coronavirus 10%
• Drug Development 7%
• Gene Editing 9%
• givosiran 18%
• Guide RNA 11%
• Inotersen 16%
• Macrolides 9%
• Nucleotide Motifs 10%
• Oral Administration 6%
• Oxazolidinones 12%
• Pandemics 8%
• patisiran 16%
• pegaptanib 13%
• Pharmaceutical Preparations 59%
• Pharmacology 10%
• Proteins 11%
• Ribosomal RNA 10%
• Risdiplam 18%
• RNA 100%
• RNA Stability 8%
• Severe Acute Respiratory Syndrome 10%
• Small Interfering RNA 6%
• Technology 5%
• Tetracyclines 10%
• Therapeutics 6%
• Vaccination 6%